LIG4 mediates Wnt signalling-induced radioresistance

Nature Communications

Volumn 7, Issue , 2016, Pages

  Jun, Sohee ^a   Jung, Youn Sang ^a   Suh, Han Na ^a   Wang, Wenqi ^a   Kim, Moon Jong ^a   Oh, Young Sun ^a   Lien, Esther M ^a   Shen, Xi ^a   Matsumoto, Yoshihisa ^b   McCrea, Pierre D ^a,c   Li, Lei ^a,c   Chen, Junjie ^a,c   Park, Jae Il ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; LIG4 PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; ATP DEPENDENT DNA LIGASE; DNA LIGASE; LIG4 PROTEIN, HUMAN; TELOMERASE; TERT PROTEIN, MOUSE;

CANCER; CELLS AND CELL COMPONENTS; CORRELATION; DNA; ENZYME ACTIVITY; GENE EXPRESSION; PROTEIN; TUMOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL CANCER CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA END JOINING REPAIR; DOWN REGULATION; ECTOPIC EXPRESSION; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINAL STEM CELL; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; RADIOSENSITIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE EXPRESSION; TISSUE MICROARRAY; TRANSACTIVATION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; COLORECTAL TUMOR; COMPUTER SIMULATION; CYTOLOGY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INTESTINE; METABOLISM; RADIATION RESPONSE; RADIATION TOLERANCE; STEM CELL; TRANSCRIPTION INITIATION; TRANSGENIC ANIMAL; TUMOR CELL LINE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA LIGASE ATP; DNA LIGASES; DNA REPAIR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINES; MICE; RADIATION TOLERANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELLS; TELOMERASE; TRANSCRIPTIONAL ACTIVATION; WNT SIGNALING PATHWAY;

EID: 84961575607     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10994     Document Type: Article

References (59)

1. Clevers, H., Loh, K. M., Nusse, R. Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 346, 1248012 (2014).
2. Clevers, H., Nusse, R. Wnt/beta-catenin signaling and disease. Cell 149, 1192-1205 (2012).
3. Polakis, P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 4, a008052 (2012).
4. Clements, W. M., Lowy, A. M., Groden, J. Adenomatous polyposis coli/betacatenin interaction and downstream targets: altered gene expression in gastrointestinal tumors. Clin. Colorectal Cancer 3, 113-120 (2003).
5. Su, L. K. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
6. Conard, R. A. Some effects of ionizing radiation on the physiology of the gastrointestinal tract: a review. Radiat. Res. 5, 167-188 (1956).
7. Mason, K. A., Withers, H. R., McBride, W. H., Davis, C. A., Smathers, J. B. Comparison of the gastrointestinal syndrome after total-body or totalabdominal irradiation. Radiat. Res. 117, 480-488 (1989).
8. Clevers, H. The intestinal crypt, a prototype stem cell compartment. Cell 154, 274-284 (2013).
9. Hai, B. et al. Concurrent transient activation of Wnt/beta-catenin pathway prevents radiation damage to salivary glands. Int. J. Radiat. Oncol. Biol. Phys. 83, e109-e116 (2012).
10. Zhao, J. et al. R-Spondin1 protects mice from chemotherapy or radiationinduced oral mucositis through the canonical Wnt/beta-catenin pathway. Proc. Natl Acad. Sci. USA 106, 2331-2336 (2009).
11. Chen, M. S. et al. Wnt/beta-catenin mediates radiation resistance of Sca1\+ progenitors in an immortalized mammary gland cell line. J. Cell Sci. 120, 468-477 (2007).
12. Bhanja, P. et al. Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice. PLoS ONE 4, e8014 (2009).
13. Zhou, W. J., Geng, Z. H., Spence, J. R., Geng, J. G. Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. Nature 501, 107-111 (2013).
14. Lento, W. et al. Loss of beta-catenin triggers oxidative stress and impairs hematopoietic regeneration. Genes Dev. 28, 995-1004 (2014).
15. Chandra, A. et al. PTH1-34 blocks radiation-induced osteoblast apoptosis by enhancing DNA repair through canonical Wnt pathway. J. Biol. Chem. 290, 157-167 (2015).
16. Chang, H. W. et al. Wnt signaling controls radiosensitivity via cyclooxygenase-2-mediated Ku expression in head and neck cancer. Int. J. Cancer 122, 100-107 (2008).
17. Woodward, W. A. et al. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl Acad. Sci. USA 104, 618-623 (2007).
18. Zhang, M., Atkinson, R. L., Rosen, J. M. Selective targeting of radiationresistant tumor-initiating cells. Proc. Natl Acad. Sci. USA 107, 3522-3527 (2010).
19. Li, Y. et al. Evidence that transgenes encoding components of theWnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl Acad. Sci. USA 100, 15853-15858 (2003).
20. Li, G. et al. MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B. Eur. J. Cancer 49, 2596-2607 (2013).
21. Li, H. Z. et al. Identification of differentially expressed genes related to radioresistance of human esophageal cancer cells. Chin. J. Cancer 29, 882-888 (2010).
22. Che, S. M., Zhang, X. Z., Liu, X. L., Chen, X., Hou, L. The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells. Dis. Esophagus 24, 265-273 (2011).
23. Kim, Y. et al. Wnt activation is implicated in glioblastoma radioresistance. Lab. Invest. 92, 466-473 (2012).
24. Kendziorra, E. et al. Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy. Carcinogenesis 32, 1824-1831 (2011).
25. Jackson, S. P., Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071-1078 (2009).
26. Deriano, L., Roth, D. B. Modernizing the nonhomologous end-joining repertoire: alternative and classical NHEJ share the stage. Annu. Rev. Genet. 47, 433-455 (2013).
27. Sonoda, E., Takata, M., Yamashita, Y. M., Morrison, C., Takeda, S. Homologous DNA recombination in vertebrate cells. Proc. Natl Acad. Sci. USA 98, 8388-8394 (2001).
28. Williams, G. J. et al. Structural insights into NHEJ: building up an integrated picture of the dynamic DSB repair super complex, one component and interaction at a time. DNA Repair (Amst) 17, 110-120 (2014).
29. Ochi, T. et al. DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair. Science 347, 185-188 (2015).
30. O'Driscoll, M. et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8, 1175-1185 (2001).
31. Oh, S., Wang, Y., Zimbric, J., Hendrickson, E. A. Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction. Nucleic Acids Res. 41, 1734-1749 (2013).
32. Nijnik, A. et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447, 686-690 (2007).
33. Felgentreff, K. et al. Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 111, 8889-8894 (2014).
34. Tilgner, K. et al. A human iPSC model of ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors. Cell Death iDffer. 20, 1089-1100 (2013).
35. Munroe, R. J. et al. Mouse mutants from chemically mutagenized embryonic stem cells. Nat. Genet. 24, 318-321 (2000).
36. Thomas, J. W., LaMantia, C., Magnuson, T. X-ray-induced mutations in mouse embryonic stem cells. Proc. Natl Acad. Sci. USA 95, 1114-1119 (1998).
37. Tichy, E. D. et al. The abundance of Rad51 protein in mouse embryonic stem cells is regulated at multiple levels. Stem Cell Res. 9, 124-134 (2012).
38. Harfouche, G., Martin, M. T. Response of normal stem cells to ionizing radiation: a balance between homeostasis and genomic stability. Mutat. Res. 704, 167-174 (2010).
39. Bao, S. et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-760 (2006).
40. Karimi-Busheri, F., Rasouli-Nia, A., Mackey, J. R., Weinfeld, M. Senescence evasion by MCF-7 human breast tumor-initiating cells. Breast Cancer Res. 12, R31 (2010).
41. Zabludoff, S. D. et al. AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies. Mol. Cancer Ther. 7, 2955-2966 (2008).
42. Fuerer, C., Nusse, R. Lentiviral vectors to probe and manipulate the Wnt signaling pathway. PLoS ONE 5, e9370 (2010).
43. Vermeulen, L. et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Biol. 12, 468-476 (2010).
44. Evans, J. et al. Registered report: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Elife 4, e07301 (2015).
45. de Sousa, E. M. F. et al. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 9, 476-485 (2011).
46. Sadanandam, A. et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 19, 619-625 (2013).
47. de Sousa, E. M., Vermeulen, L., Richel, D., Medema, J. P. Targeting Wnt signaling in colon cancer stem cells. Clin. Cancer Res. 17, 647-653 (2011).
48. Srivastava, M. et al. An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell 151, 1474-1487 (2012).
49. Riballo, E. et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol. 9, 699-702 (1999).
50. Yan, K. S. et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl Acad. Sci. USA 109, 466-471 (2012).
51. Tian, H. et al. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 478, 255-259 (2011).
52. Metcalfe, C., Kljavin, N. M., Ybarra, R., de Sauvage, F. J. Lgr5\+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 14, 149-159 (2014).
53. Munoz, J. et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '\+4' cell markers. EMBO J. 31, 3079-3091 (2012).
54. Park, J. I. et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66-72 (2009).
55. Jung, H. Y.,Wang, X., Jun, S., Park, J. I. Dyrk2-associated EDD-DDB1-VprBP E3 ligase inhibits telomerase by TERT degradation. J. Biol. Chem. 288, 7252-7262 (2013).
56. Frank, K. M. et al. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 5, 993-1002 (2000).
57. Jung, H. Y. et al. PAF and EZH2 induce Wnt/beta-catenin signaling hyperactivation. Mol. Cell 52, 193-205 (2013).
58. Jun, S. et al. PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. Cell Rep. 5, 314-322 (2013).
59. Jung, Y. S., Jun, S., Lee, S. H., Sharma, A., Park, J. I. Wnt2 complements Wnt/beta-catenin signaling in colorectal cancer. Oncotarget 6, 37257-37268 (2015).